Tecan Group AG TCHBF
271.00 USD 0.00 (+0.00%)
At closeNov 3, 2026, 4:00 PM EST
249.40 Day range 249.40
155.25 52-week range 271.00
- YTD
- +69.85%
- 1 year
- +49.02%
- Market cap
- 3.34B
- EPS (ttm)
- -11.54
- YTD return
- +69.85%
- 1-year return
- +49.02%
- Volume
- 1
- Avg volume
- 4
- Open
- 249.40
- Previous close
- 271.00
- Day's range
- 249.40 – 249.40
- 52-week range
- 155.25 – 271.00
- Earnings date
- Aug 11, 2026
2Y -6.00 (-2.17%)
Next earnings
Aug 11, 2026
Expected Aug 11, 2026. Consensus EPS estimate 3.11.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Aug 11, 2026 | Jun 30, 2026 | 3.11 | — | — | — |
| Mar 16, 2026 | Dec 31, 2025 | 4.28 | 5.37 | +1.09 | +25.47% |
| Aug 12, 2025 | Jun 30, 2025 | 3.16 | 1.77 | -1.39 | -43.99% |
| Mar 10, 2025 | Dec 31, 2024 | 4.03 | 3.89 | -0.14 | -3.47% |
| Aug 13, 2024 | Jun 30, 2024 | 4.94 | 1.95 | -2.99 | -60.53% |
| Feb 27, 2024 | Dec 31, 2023 | 6.85 | 7.18 | +0.33 | +4.82% |
News
How to Invest in AI Drug Discovery 
Tecan Group AG (TCGGY) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript 
Tecan Group AG (TCGGY) Q2 2026 Earnings Call Transcript 
Tecan Accelerates Data-Driven Lab Journey With Agentic AI Developments Powered by NVIDIA 
Tecan to create Data-Driven Labs with NVIDIA 
Tecan Group AG (TCGGY) Analyst/Investor Day Transcript 
Tecan Group AG (TCGGY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript 
Cellares Selects Five Best-in-Class Technology Providers, Tecan, Advanced Instruments, Cytek Biosciences, Slingshot Biosciences and AltemisLab, to Expand Cell Q's Capabilities in Meeting Demands for Commercial Scale Cell Therapy Quality Control 
Tecan Group AG (TCHBF) Q2 2025 Earnings Call Transcript 
Tecan Group AG (TCHBF) Q4 2024 Earnings Call Transcript
Your note
Sign in to keep a note on TCHBF — it syncs with the Stock Master app.